Cindy R. Tahl

2019

In 2019, Cindy R. Tahl earned a total compensation of $2.8M as General Counsel and Corporate Secretary at Fate Therapeutics, a 104% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$150,938
Option Awards$1,547,898
Salary$375,000
Stock Awards$744,750
Total$2,818,586

Tahl received $1.5M in option awards, accounting for 55% of the total pay in 2019.

Tahl also received $150.9K in non-equity incentive plan, $375K in salary and $744.8K in stock awards.

Rankings

In 2019, Cindy R. Tahl's compensation ranked 4,341st out of 13,971 executives tracked by ExecPay. In other words, Tahl earned more than 68.9% of executives.

ClassificationRankingPercentile
All
4,341
out of 13,971
69th
Division
Manufacturing
1,597
out of 5,692
72nd
Major group
Chemicals And Allied Products
559
out of 2,189
75th
Industry group
Drugs
471
out of 1,875
75th
Industry
Biological Products, Except Diagnostic Substances
102
out of 389
74th
Source: SEC filing on April 21, 2021.

Tahl's colleagues

We found three more compensation records of executives who worked with Cindy R. Tahl at Fate Therapeutics in 2019.

2019

J Wolchko

Fate Therapeutics

Chief Executive Officer

2019

Bahram Valamehr

Fate Therapeutics

Chief Research and Development Officer

2019

Daniel Shoemaker

Fate Therapeutics

Chief Scientific Officer

News

In-depth

You may also like